Kyoko Nagao
Research Subjects
Kyoko Nagao has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
Thierry Morlet
Nemours Biomedical Research, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE, USA
9 shared publicationsKenneth de Jong
Linguist, Indiana Univ., Bloomington, IN
7 shared publicationsByung-Jin Lim
East Asian Lang. & Lit., Univ. of Wisconsin, Madison, WI
6 shared publications- Thierry Morlet
School of Communication Sciences and Disorders, University of Memphis, Memphis, TN 38152, USA
6 shared publications L. Ashleigh Greenwood
A Auditory Physiology and Psychoacoustics Research Laboratory , Center for Pediatric Auditory Speech and Sciences, Nemours/Alfred I. duPont Hospital for Children , Wilmington , DE , USA
4 shared publicationsRebecca G. Gaffney
A Auditory Physiology and Psychoacoustics Research Laboratory , Center for Pediatric Auditory Speech and Sciences, Nemours/Alfred I. duPont Hospital for Children , Wilmington , DE , USA
4 shared publications
Latest Publications
- 17 May 2023
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 33 (4) , 143-148
Comparison of Fidgeting in Adolescents with Attention-Deficit/Hyperactivity Disorder Between Before and After Stimulant Medication Intake
Objective: Fidgeting is a common symptom in patients with attention-deficit hyperactivity disorder (ADHD). The current study investigated ADHD stimulant medication effects on fidgeting in adolescents with ADHD during a short research study session using wrist-worn accelerometers. Method: Adolescents with ADHD who had been taking stimulant medications (ADHD group) and adolescents without ADHD (control group) participated in the study. Accelerometer data were obtained from both wrists of each participant to track their hand movements during two hearing testing sessions. All subjects in the ADHD group abstained from their stimulant medications for at least 24 hours before their first session (off-med session). The second session (on-med session) was conducted about 60–90 minutes after medication intake. The control group participated in two sessions in a similar time frame. Results: The current study focuses on relationships between hand movements and stimulant medication in adolescents with ADHD. Both conditions were compared to evaluate the relationship of hand movements and stimulant medication. We hypothesized the ADHD group will exhibit less hand movements during the on-medication session in comparison to off-medication session. Conclusion: Wrist-worn accelerometer measures obtained during nonphysical tasks in a short duration may not provide hand movement differences between on-med and off-med conditions in adolescents with ADHD. ClinicalTrials.gov Identifier: NCT04577417.
- 17 May 2023
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 33 (4) , 143-148
Comparison of Fidgeting in Adolescents with Attention-Deficit/Hyperactivity Disorder Between Before and After Stimulant Medication Intake
Objective: Fidgeting is a common symptom in patients with attention-deficit hyperactivity disorder (ADHD). The current study investigated ADHD stimulant medication effects on fidgeting in adolescents with ADHD during a short research study session using wrist-worn accelerometers. Method: Adolescents with ADHD who had been taking stimulant medications (ADHD group) and adolescents without ADHD (control group) participated in the study. Accelerometer data were obtained from both wrists of each participant to track their hand movements during two hearing testing sessions. All subjects in the ADHD group abstained from their stimulant medications for at least 24 hours before their first session (off-med session). The second session (on-med session) was conducted about 60–90 minutes after medication intake. The control group participated in two sessions in a similar time frame. Results: The current study focuses on relationships between hand movements and stimulant medication in adolescents with ADHD. Both conditions were compared to evaluate the relationship of hand movements and stimulant medication. We hypothesized the ADHD group will exhibit less hand movements during the on-medication session in comparison to off-medication session. Conclusion: Wrist-worn accelerometer measures obtained during nonphysical tasks in a short duration may not provide hand movement differences between on-med and off-med conditions in adolescents with ADHD. ClinicalTrials.gov Identifier: NCT04577417.
- Open Access
- 4 August 2020
- Published by MDPI AG in Diagnostics
- Vol. 10 (8) , 554
Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions
Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by a deficiency of one of the enzymes involved in the degradation of glycosaminoglycans. Hearing loss is a common clinical presentation in MPS. This paper reviews the literature on hearing loss for each of the seven recognized subtypes of MPS. Hearing loss was found to be common in MPS I, II, III, IVA, VI, and VII, and absent from MPS IVB and MPS IX. MPS VI presents primarily with conductive hearing loss, while the other subtypes (MPS I, MPS II, MPS III, MPS IVA, and MPS VII) can present with any type of hearing loss (conductive, sensorineural, or mixed hearing loss). The sensorineural component develops as the disease progresses, but there is no consensus on the etiology of the sensorineural component. Enzyme replacement therapy (ERT) is the most common therapy utilized for MPS, but the effects of ERT on hearing function have been inconclusive. This review highlights a need for more comprehensive and multidisciplinary research on hearing function that includes behavioral testing, objective testing, and temporal bone imaging. This information would allow for better understanding of the progression and etiology of hearing loss. Owing to the prevalence of hearing loss in MPS, early diagnosis of hearing loss and annual comprehensive audiological evaluations are recommended.
- 4 August 2020
- Published by MDPI AG in Diagnostics
- Vol. 10 (8) , 554
Open AccessHearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions
Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by a deficiency of one of the enzymes involved in the degradation of glycosaminoglycans. Hearing loss is a common clinical presentation in MPS. This paper reviews the literature on hearing loss for each of the seven recognized subtypes of MPS. Hearing loss was found to be common in MPS I, II, III, IVA, VI, and VII, and absent from MPS IVB and MPS IX. MPS VI presents primarily with conductive hearing loss, while the other subtypes (MPS I, MPS II, MPS III, MPS IVA, and MPS VII) can present with any type of hearing loss (conductive, sensorineural, or mixed hearing loss). The sensorineural component develops as the disease progresses, but there is no consensus on the etiology of the sensorineural component. Enzyme replacement therapy (ERT) is the most common therapy utilized for MPS, but the effects of ERT on hearing function have been inconclusive. This review highlights a need for more comprehensive and multidisciplinary research on hearing function that includes behavioral testing, objective testing, and temporal bone imaging. This information would allow for better understanding of the progression and etiology of hearing loss. Owing to the prevalence of hearing loss in MPS, early diagnosis of hearing loss and annual comprehensive audiological evaluations are recommended.
- 25 January 2019
- Published by Taylor & Francis in International Journal of Audiology
- Vol. 58 (4) , 213-223
Auditory event-related potentials and function of the medial olivocochlear efferent system in children with auditory processing disorders
Objective: The objectives were to investigate the function of central auditory pathways and of the medial efferent olivocochlear system (MOCS). Design: Event-related potentials (ERP) were recorded following the delivery of the stimulus /da/ in quiet and in ipsilateral, contralateral, and binaural noise conditions and correlated to the results of the auditory processing disorders (APD) diagnostic test battery. MOCS function was investigated by adding ipsilateral, contralateral, and binaural noise to transient evoked otoacoustic emission recordings. Auditory brainstem responses and pure tone audiogram were also evaluated. Study Sample: Nineteen children (7 to 12 years old) with APD were compared with 24 age-matched controls. Results: Otoacoustic emissions and ABR characteristics did not differ between groups, whereas ERP latencies were significantly longer and of higher amplitudes in APD children than in controls, in both quiet and noise conditions. The MOCS suppression was higher in APD children. Conclusions: Findings indicate that children with APD present with neural deficiencies in both challenging and nonchallenging environments with an increase in the timing of several central auditory processes correlated to their behavioural performances. Meanwhile, their modulation of the auditory periphery under noisy conditions differs from control children with higher suppression.
- 25 January 2019
- Published by Taylor & Francis in International Journal of Audiology
- Vol. 58 (4) , 213-223
Auditory event-related potentials and function of the medial olivocochlear efferent system in children with auditory processing disorders
Objective: The objectives were to investigate the function of central auditory pathways and of the medial efferent olivocochlear system (MOCS). Design: Event-related potentials (ERP) were recorded following the delivery of the stimulus /da/ in quiet and in ipsilateral, contralateral, and binaural noise conditions and correlated to the results of the auditory processing disorders (APD) diagnostic test battery. MOCS function was investigated by adding ipsilateral, contralateral, and binaural noise to transient evoked otoacoustic emission recordings. Auditory brainstem responses and pure tone audiogram were also evaluated. Study Sample: Nineteen children (7 to 12 years old) with APD were compared with 24 age-matched controls. Results: Otoacoustic emissions and ABR characteristics did not differ between groups, whereas ERP latencies were significantly longer and of higher amplitudes in APD children than in controls, in both quiet and noise conditions. The MOCS suppression was higher in APD children. Conclusions: Findings indicate that children with APD present with neural deficiencies in both challenging and nonchallenging environments with an increase in the timing of several central auditory processes correlated to their behavioural performances. Meanwhile, their modulation of the auditory periphery under noisy conditions differs from control children with higher suppression.
- Open Access
- 1 January 2019
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 7
Cochlear implantation in a patient with mucopolysaccharidosis IVA
Mucopolysaccharidosis IVA (OMIM 253000; also known as Morquio A syndrome) is associated with skeletal, airway, and hearing abnormalities. Cochlear implantation is an effective intervention for patients with severe-to-profound hearing loss. Patients can gain substantial improvement in auditory performance, speech perception, and their quality of life from cochlear implantation. Although severe progressive sensorineural hearing loss is a common feature of mucopolysaccharidosis IVA, no detailed description of cochlear implantation for mucopolysaccharidosis IVA has been reported. To review the effectiveness and special considerations associated with cochlear implantation in patients with mucopolysaccharidosis IVA, we here report the case of cochlear implantation in mucopolysaccharidosis IVA by a multidisciplinary team. A retrospective chart review was conducted on a 34-year-old female with mucopolysaccharidosis IVA, who received a cochlear implant. Audiometric thresholds, speech perception scores, and cochlear implant processor mapping information were reviewed during the first 12 months following cochlear implantation. The results of audiological tests indicate improved hearing thresholds as well as remarkable enhancement of speech perception skills over 12 months of cochlear implant use. Cochlear implantation improved auditory performance in a mucopolysaccharidosis IVA patient with postlingually severe-to-profound sensorineural hearing loss. The benefits of cochlear implantation could be meaningful for other Morquio patients with progressive hearing loss, although the risks of surgery and anesthesia should be carefully considered by a multidisciplinary team of experts during the cochlear implant candidacy process.
- 1 January 2019
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 7
Open AccessCochlear implantation in a patient with mucopolysaccharidosis IVA
Mucopolysaccharidosis IVA (OMIM 253000; also known as Morquio A syndrome) is associated with skeletal, airway, and hearing abnormalities. Cochlear implantation is an effective intervention for patients with severe-to-profound hearing loss. Patients can gain substantial improvement in auditory performance, speech perception, and their quality of life from cochlear implantation. Although severe progressive sensorineural hearing loss is a common feature of mucopolysaccharidosis IVA, no detailed description of cochlear implantation for mucopolysaccharidosis IVA has been reported. To review the effectiveness and special considerations associated with cochlear implantation in patients with mucopolysaccharidosis IVA, we here report the case of cochlear implantation in mucopolysaccharidosis IVA by a multidisciplinary team. A retrospective chart review was conducted on a 34-year-old female with mucopolysaccharidosis IVA, who received a cochlear implant. Audiometric thresholds, speech perception scores, and cochlear implant processor mapping information were reviewed during the first 12 months following cochlear implantation. The results of audiological tests indicate improved hearing thresholds as well as remarkable enhancement of speech perception skills over 12 months of cochlear implant use. Cochlear implantation improved auditory performance in a mucopolysaccharidosis IVA patient with postlingually severe-to-profound sensorineural hearing loss. The benefits of cochlear implantation could be meaningful for other Morquio patients with progressive hearing loss, although the risks of surgery and anesthesia should be carefully considered by a multidisciplinary team of experts during the cochlear implant candidacy process.
- 25 October 2018
- Published by SAGE Publications in Telemedicine and e-Health
- Vol. 25 (10) , 973-978
Tablet-Based Hearing Test Among Child Clinical Populations: Performance and Preference
Background and Introduction: Tablet-based automated audiometry applications are a recent alternative method to perform pure-tone hearing testing. Children, in particular, might benefit from such apps because of the game-like interface. However, how children perceive this alternative approach has not been well studied. This study examined children's preference of hearing test and a relationship between their test preference and hearing test results. Materials and Methods: Forty children 6–12 years of age completed a pure-tone hearing test in both the tablet-based automated (tablet) method and the conventional method. Hearing thresholds were measured at 0.5, 1, 2, 4, 6, and 8 kHz in each ear. An exit interview was conducted to obtain each child's test preference. Results: We found that 59% of the children preferred the tablet method when compared to the conventional method. Preference to the tablet method was stronger in the younger children (6 years) than older children (7–12 years). The linear regression analyses suggest that test preference does not affect the hearing test results in the conventional method, but does negatively affect the results in the tablet method. In addition, poor performance was found among children with a clinical diagnosis, in particular, in the tablet method. Discussion: These results suggest that hearing thresholds may be overestimated in children, especially those with clinical diagnosis such as attention or behavioral issues in the tablet method. Future work is needed to determine which clinical populations have potential benefit from a tablet method. Conclusions: Children's test preference is not a good index of hearing test accuracy.
- 25 October 2018
- Published by SAGE Publications in Telemedicine and e-Health
- Vol. 25 (10) , 973-978
Tablet-Based Hearing Test Among Child Clinical Populations: Performance and Preference
Background and Introduction: Tablet-based automated audiometry applications are a recent alternative method to perform pure-tone hearing testing. Children, in particular, might benefit from such apps because of the game-like interface. However, how children perceive this alternative approach has not been well studied. This study examined children's preference of hearing test and a relationship between their test preference and hearing test results. Materials and Methods: Forty children 6–12 years of age completed a pure-tone hearing test in both the tablet-based automated (tablet) method and the conventional method. Hearing thresholds were measured at 0.5, 1, 2, 4, 6, and 8 kHz in each ear. An exit interview was conducted to obtain each child's test preference. Results: We found that 59% of the children preferred the tablet method when compared to the conventional method. Preference to the tablet method was stronger in the younger children (6 years) than older children (7–12 years). The linear regression analyses suggest that test preference does not affect the hearing test results in the conventional method, but does negatively affect the results in the tablet method. In addition, poor performance was found among children with a clinical diagnosis, in particular, in the tablet method. Discussion: These results suggest that hearing thresholds may be overestimated in children, especially those with clinical diagnosis such as attention or behavioral issues in the tablet method. Future work is needed to determine which clinical populations have potential benefit from a tablet method. Conclusions: Children's test preference is not a good index of hearing test accuracy.
- 1 September 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 125 (1-2) , 18-37
Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA
- 1 September 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 125 (1-2) , 18-37
Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA
- 1 July 2018
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 110, 87-92
Is there a clinical application for tablet-based automated audiometry in children?
- 1 July 2018
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 110, 87-92
Is there a clinical application for tablet-based automated audiometry in children?
- 3 May 2018
- Published by Springer Nature in Journal of Neurology
- Vol. 265 (7) , 1580-1589
Auditory function in Pelizaeus–Merzbacher disease
Pelizaeus–Merzbacher disease (PMD; MIM 312080), an inherited defect of central nervous system myelin formation, affects individuals in many ways, including their hearing and language abilities. The aim of this study was to assess the auditory abilities in 18 patients with PMD by examining the functional processes along the central auditory pathways using auditory brainstem responses (ABR) and cortical auditory evoked potentials (CAEP) in response to speech sounds. The significant ABR anomalies confirm the existence of dyssynchrony previously described at the level of the brainstem in patients with PMD. Despite the significant auditory dyssynchrony observed at the level of the brainstem, CAEPs were present in most patients, albeit somehow abnormal in terms of morphology and latency, resembling a type of auditory neuropathy spectrum disorder.
- 3 May 2018
- Published by Springer Nature in Journal of Neurology
- Vol. 265 (7) , 1580-1589
Auditory function in Pelizaeus–Merzbacher disease
Pelizaeus–Merzbacher disease (PMD; MIM 312080), an inherited defect of central nervous system myelin formation, affects individuals in many ways, including their hearing and language abilities. The aim of this study was to assess the auditory abilities in 18 patients with PMD by examining the functional processes along the central auditory pathways using auditory brainstem responses (ABR) and cortical auditory evoked potentials (CAEP) in response to speech sounds. The significant ABR anomalies confirm the existence of dyssynchrony previously described at the level of the brainstem in patients with PMD. Despite the significant auditory dyssynchrony observed at the level of the brainstem, CAEPs were present in most patients, albeit somehow abnormal in terms of morphology and latency, resembling a type of auditory neuropathy spectrum disorder.
- 1 April 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 123 (4) , 472-478
Neurophysiology of hearing in patients with mucopolysaccharidosis type IV
- 1 April 2018
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 123 (4) , 472-478
Neurophysiology of hearing in patients with mucopolysaccharidosis type IV
- 1 October 2017
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 142 (4_Suppleme) , 2541
Evaluating the validity and efficiency of tablet audiometry in school-age children
Tablet-based automated audiometry offers a portable alternative to traditional audiometry. The limited research available (e.g., Rourke et al., 2016) supports the clinical use of automated audiometry for pediatric hearing screenings, but its accuracy in children and efficiency outside of clinical environments is undetermined. This study’s objective is to evaluate the validity and efficiency of automated audiometry in school-age children. This initial phase aimed to establish its validity in a clinical setting. Hearing thresholds for 0.5, 1, 2, 4, 6, and 8 kHz were collected in children ages 6–12 years old using standard audiometry and an iPad app automated audiometry in a sound-proof booth. Tympanometry, acoustic reflex thresholds, and distortion product otoacoustic emissions were administered to examine peripheral hearing function. Preliminary results of 16 children show no significant difference between the two test durations. Automated audiometry thresholds were within 5 dB of the standard audiometry thresholds for each tested frequency, except at 6 kHz where they were within 7dB. There was no test preference among the participants. Our preliminary results support the use of automated audiometry in children. Current testing is evaluating its validity and reliability under less ideal testing environments. [Work supported by NIH COBRE Grant P30GM114736 and the Nemours Foundation.]
- 1 October 2017
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 142 (4_Suppleme) , 2541
Evaluating the validity and efficiency of tablet audiometry in school-age children
Tablet-based automated audiometry offers a portable alternative to traditional audiometry. The limited research available (e.g., Rourke et al., 2016) supports the clinical use of automated audiometry for pediatric hearing screenings, but its accuracy in children and efficiency outside of clinical environments is undetermined. This study’s objective is to evaluate the validity and efficiency of automated audiometry in school-age children. This initial phase aimed to establish its validity in a clinical setting. Hearing thresholds for 0.5, 1, 2, 4, 6, and 8 kHz were collected in children ages 6–12 years old using standard audiometry and an iPad app automated audiometry in a sound-proof booth. Tympanometry, acoustic reflex thresholds, and distortion product otoacoustic emissions were administered to examine peripheral hearing function. Preliminary results of 16 children show no significant difference between the two test durations. Automated audiometry thresholds were within 5 dB of the standard audiometry thresholds for each tested frequency, except at 6 kHz where they were within 7dB. There was no test preference among the participants. Our preliminary results support the use of automated audiometry in children. Current testing is evaluating its validity and reliability under less ideal testing environments. [Work supported by NIH COBRE Grant P30GM114736 and the Nemours Foundation.]